Septerna (SEPN) Depreciation & Amortization (CF) (2023 - 2026)
Septerna's quarterly Depreciation & Amortization (CF) came in at $421000.0 in Q1 2026, up 6.05% year-on-year from $397000.0 in Q1 2025, and up 4.99% quarter-over-quarter from $401000.0 in Q4 2025.
Septerna has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $421000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 6.05% year-over-year to $421000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 9.85% YoY), and the FY2025 full-year result was $1.6 million, up 14.49% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $421000.0, up from $401000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $421000.0 in Q1 2026, with the low at $243000.0 in Q4 2023.
- Average Depreciation & Amortization (CF) over 4 years is $366900.0, with a median of $392500.0 recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) soared 59.67% in 2024 and increased 3.35% in 2025.
- Tracing SEPN's Depreciation & Amortization (CF) over 4 years: stood at $243000.0 in 2023, then surged by 59.67% to $388000.0 in 2024, then climbed by 3.35% to $401000.0 in 2025, then gained by 4.99% to $421000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $421000.0 (Q1 2026), $401000.0 (Q4 2025), and $401000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421,000.00 |
| Mar 31, 2026 | 421,000.00 |
| Dec 31, 2025 | 401,000.00 |
| Dec 31, 2025 | 401,000.00 |
| Sep 30, 2025 | 401,000.00 |
| Sep 30, 2025 | 401,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | 397,000.00 |
| Mar 31, 2025 | 397,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Mar 31, 2024 | 316,000.00 |
| Mar 31, 2024 | 316,000.00 |
| Dec 31, 2023 | 243,000.00 |
| Dec 31, 2023 | 243,000.00 |